News and clinical updates for the cath lab specialist.
- Tweets 3,191
- Following 3,235
- Followers 12,188
- Likes 233
Build a smarter concomitant LAAC program. Explore how dedicated a high-performing hospital views their AFib workflow as a total program and not just individual procedures.
hubs.ly/Q04xb8CX0
265
Protect standalone WATCHMAN™ efficiency while expanding concomitant care. Discover strategies for eligible patient identification, case scheduling, resource alignment, and sustainable LAAC program growth.
Register today: hubs.ly/Q04xg0jr0
330
The FDA has approved the SELUTION SLR™ PTCA drug-eluting balloon, marking an important milestone for coronary intervention and expanding treatment options for patients. Learn more about the approval:
hubs.ly/Q04x-f250)
1
3
384
Concomitant LAAC is growing—is your workflow ready? Join Episode 2 of WATCHMAN™ LAAC in Practice for practical insights on scheduling, case optimization, care team alignment, and scalable program design.
hubs.ly/Q04xb6yH0
1
294
The Ambulatory Surgery Center Association (ASCA) is urging CMS to eliminate the ASC weight scalar, warning that proposed 2027 payment cuts could limit patient access to lower-cost surgery centers.
hubs.ly/Q04x39W30
2
366
One coordinated case. Two procedures. Considerations for program growth. Learn how strategic scheduling and coordinated pathways can support concomitant LAAC and AF ablation without compromising throughput.
Register: hubs.ly/Q04xb3kJ0
309
New Supplement: CIED Management 2026
Explore scalable workflows, responsible AI use, and strategies for addressing transmission volumes, staffing constraints, alert fatigue, interoperability gaps, and financial pressures—plus an RFP capability matrix.
hubs.ly/Q04wXC540]
356
How can programs expand concomitant LAAC and AF ablation without disrupting standalone WATCHMAN™ efficiency? Explore practical strategies for smarter scheduling, patient routing, and sustainable growth.
Register: hubs.ly/Q04xfYGy0
1
325
@MortonKern and @DrJayMohan: Our Top Tips for a New Fellow Starting in the Cath Lab
Listen at the link or jump to the article:
hubs.ly/Q04w-S380
#cardiotwitter #medtwitter
1
2
416
Investment in cardiovascular ASCs continues to gain momentum.
The sale of a physician-owned cardiovascular surgery center reflects continued growth in outpatient cardiovascular care and confidence in the ASC market.
hubs.ly/Q04s7BTz0
1
387
A record number of ambulatory surgery centers are now included in The Leapfrog Group's quality and safety ratings, expanding transparency and benchmarking across outpatient care.
hubs.ly/Q04s6Lvy0 #cardiotwitter
439
Ascension has completed its acquisition of AMSURG, adding approximately 300 ASCs to its national network.
“Healthcare is increasingly moving beyond the traditional hospital setting,” said Ascension CEO Eduardo Conrado.
Read more: hubs.ly/Q04nNNTp0
377
Code blue in the cath lab is not the time to learn team roles. HF simulation helped this procedural team practice emergencies, improve teamwork, and strengthen readiness for rare but high-risk events.
Read more: hubs.ly/Q04pbD150
1
347
What can firsthand experience reveal about the new Shockwave C2 Aero? CLD's Partner Spotlight features practical insights into how #ShockwaveC2Aero is being used to approach coronary calcium modification in real-world cases. Find more:
hubs.ly/Q04n3rF40 @ShockwaveIVL
224
Dean J. Kereiakes, MD, reviews the DynamX Bioadaptor, including its mechanism of action, restoration of vessel motion, and clinical data in PCI.
Read more: hubs.ly/Q04n6yh40
2
3
353
How might improved deliverability and rewrap affect IVL workflow? See how operators are discussing Shockwave C2 Aero and its use in complex calcified coronary disease.
hubs.ly/Q04jPW4g0 #cardiotwitter @ShockwaveIVL
1
1
335
“The right patient to the right facility for the right procedure — and at the right price.” Kristen Richards explores how cardiovascular ASCs can help expand access, improve convenience, and support lower-cost care delivery.
hubs.ly/Q04kM-4B0
207
Technical skill matters in the cath lab. So does how patients are spoken to, heard, and supported.
In “Imagine,” Terri L. Wolf, RCIS, underscores the importance of compassion as part of care.
Read more: hubs.ly/Q04mG57q0
1
1
285
Advanced heart failure specialist Matthew Gonzalez, MD, shares practical insights for using the CardioMEMS™ HF System, made by Abbott, in real-world practice.
Read more: hubs.ly/Q04lz24N0
#CardioMEMS #cardiotwitter @AbbottCardio #HeartFailure
233
Advanced heart failure specialist Matthew Gonzalez, MD, shares practical insights for using the CardioMEMS™ HF System, made by Abbott, in real-world practice.
Read more: hubs.ly/Q04lzmTb0
#CardioMEMS #cardiotwitter @AbbottCardio #HeartFailure
1
183
What are Yousif Ahmad, MBBS, PhD, and Brett Wanamaker, MD, seeing with Shockwave C2 Aero? Explore their perspective on deliverability, compact rewrap, and use in complex coronary calcium modification.
hubs.ly/Q04jPPLh0 #cardiotwitter @ShockwaveIVL
140
What does the Medicare experience tell us about PCI in ASCs? Drs Morton Kern and Arnold Seto, and Bailey Richardson, MSN, AGNP, discuss patient characteristics, volume trends, and outcomes as outpatient coronary intervention expands.
hubs.ly/Q04kLML70
110
What can IVUS + NIRS reveal that angiography may miss? Dhananjay Chatterjee, MD, discusses how the Makoto™ Intravascular Imaging System with DualPro helps identify plaque burden, calcium, and vulnerable lesions to better guide PCI.
hubs.ly/Q04jd1_n0
169
How are operators approaching thrombus-heavy PAD, ALI, and ISR? Miranda and Raja discuss the role of the Rotarex™ Catheter System, IVUS-guided decision-making, and practical strategies for managing complex peripheral disease.
hubs.ly/Q04jnDZ80
1
1
300
“Under-promised and over-delivered.” Christopher L. Brown, MD, shares his early experience with Shockwave C2 Aero, highlighting improved deliverability, rewrap, and multivessel flexibility in complex calcified PCI.
bit.ly/4fYV0sW @ShockwaveIVL #cardiotwitter
1
5
559
Usman and Zakir highlight how the DETOUR™ System from Endologix may expand revascularization options in complex femoropopliteal disease, including long lesions, prior stents, and heavily calcified anatomy.
hubs.ly/Q04j45pD0
168
New MAUDE Analysis Highlights Real-World Mechanical Thrombectomy Complications
At SIR 2026, Chloe Issa, MD, and Sarah Montaquila, DO, revealed a key gap between complication frequency and severity in venous and pulmonary thrombectomy systems.
hubs.ly/Q04hmkLf0
149
What can firsthand experience reveal about the new Shockwave C2 Aero? CLD's Partner Spotlight features practical insights into how #ShockwaveC2Aero is being used to approach coronary calcium modification in real-world cases. Find more:
hubs.ly/Q04hjNyZ0 @ShockwaveIVL
1
227
As cardiovascular procedures continue shifting to the ASC, Marc Toth highlights 4 key considerations for a successful outmigration strategy, including design, digital monitoring, virtual rehab, and long-term scalability.
hubs.ly/Q04fqxxb0 #cardiotwitter #ASC #cardiology
174
IVL keeps advancing, with new patent activity, FIH platform use, pivotal coronary trial progress, and real-world data supporting an IVL-first strategy in complex calcified disease. Latest: hubs.ly/Q04h7bf00
@ShockwaveIVL @BostonSci @fastwavemedical @CagentVascular
1
1
194
What can firsthand experience reveal about the new Shockwave C2 Aero? CLD's Partner Spotlight features practical insights into how #ShockwaveC2Aero is being used to approach coronary calcium modification in real-world cases. Find more:
hubs.ly/Q04gkfWD0 @ShockwaveIVL
1
199
What does a high-functioning hybrid OBL/ASC look like in practice? Timothy Dao, MD, and Rikesh Patel, MD, share how HeartPlace is using careful case selection, efficiency, and safety to expand outpatient cardiovascular care in Texas. hubs.ly/Q04fqxBT0 #cardiotwitter #ASC
1
201
Microplastics as Triggers of Immunothrombosis: Linking Environmental Exposure to Cardiovascular Events
Small particles, serious consequences. Emerging research links everyday exposure to immune-driven clotting and cardiovascular risk.
Learn more: hubs.ly/Q04fskMt0 @hmpVDM
1
159
Advanced heart failure specialist Matthew Gonzalez, MD, shares practical insights for using the CardioMEMS™ HF System, made by Abbott, in real-world practice.
Read more: hubs.ly/Q04dz6BV0
#CardioMEMS #cardiotwitter @AbbottCardio #HeartFailure
2
244
Coronary interventions are moving into ASCs. What’s your system’s plan? Marc Toth and Derek Mitzel outline why an ambulatory strategy now needs clear case selection, escalation pathways, staffing, and a system-wide access + growth playbook.
hubs.ly/Q049KkJP0 #cardiotwitter
158
RCT data are coming for pelvic vein embolization. Co-PI @RonaldWinokurMD on the EMBOLIZE trial: venography vs venography + ovarian/pelvic vein embolization for pelvic venous disease pelvic pain (pain + QoL).
hubs.ly/Q0494gJR0 @PenVascular
205
Ultra-high-pressure balloon strategy in complex PCI: @KAlaswadMD shares how the OPN NC (35 atm) can tackle resistant calcium/underexpanded stents, with trial data (eg, VICTORY) supporting stent expansion comparable to IVL in selected cases.
hubs.ly/Q04clvfb0
1
8
21
2,123
Leapfrog is expanding ASC public reporting: nearly 4,000 centers will be rated starting late July 2026, using CMS measures, accreditation-verified standards, and a redesigned ASC Survey 2.0.
hubs.ly/Q049K9Ms0 #cardiotwitter #cardiology #medtwitter
257
Daniel Aboyeji, RN, BSc, asks: During arrest from abrupt unprotected left main occlusion, is a brief “controlled pause” in CPR (<1-2 min) ever justified to regain guide/wire position and restore flow? @MortonKern + colleagues weigh in hubs.ly/Q04bpWsg0 #cardiotwitter
2
6
29
4,782
Ultra-high-pressure balloon strategy in complex PCI: @KAlaswadMD shares how the OPN NC (35 atm) can tackle resistant calcium/underexpanded stents, with trial data (eg, VICTORY) supporting stent expansion comparable to IVL in selected cases.
hubs.ly/Q0494XS90
2
5
36
2,597
Tonight at 7 PM ET. If you treat calcified PAD—or help run a PAD program—join this live 60-minute webinar on IVL’s clinical role and the practical economic/operational considerations that drive adoption.
Register: hubs.ly/Q044PGJY0
227
If you’ve been meaning to register, here’s the nudge: this is a 60-minute, decision-relevant session—built around what determines real-world adoption (not theory).
IVL in PAD • Live 3/25 at 7 PM ET
Save your seat: hubs.ly/Q044PCrl0
251
Built for clinicians + program leaders.
➔ Clinicians: navigate system constraints.
➔ Admins: understand operational/economic drivers of adoption.
IVL in PAD live webinar: 3/25, 7 PM ET (60 min). hubs.ly/Q044PycM0
1
190
Rural access win: Amanda Ryan, DO, shares how her hybrid OBL/ASC in New Mexico is cutting multi-hour travel for cardiac and vascular care, and what it takes to build a mission-driven program in a 3-county region.
hubs.ly/Q045yJrf0
201
Presented at EuroPCR, EMPOWER CAD tested an intravascular lithotripsy-first PCI strategy in women with severely calcified CAD, showing 86.9% procedural success at 30 days + 0.2% serious angiographic complications.
Learn more: hubs.ly/Q045d_Bb0 #cardiotwitter @ShockwaveIVL
280
Coronary calcium: Margaret McEntegart, MD, on why IVL can be safe, effective, and cost efficient, with analyses suggesting lower per-case costs vs rotational atherectomy.
hubs.ly/Q045dYGx0 #cardiotwitter @mbmcentegart @ShockwaveIVL
207
How a Virginia cardiology group built an ASC around EP + peripheral first, then planned ahead for a cath lab with CON approval. Practical lessons on staffing, workflow, and patient selection from Ann E. Honeycutt, MSN.
hubs.ly/Q045yJWk0
243
Treat calcified PAD? “Economics” often determines what gets adopted. Get practical IVL in PAD insights: care pathways + reimbursement/coding/coverage + implementation. Live 3/25, 7 PM ET: hubs.ly/Q044Pvjy0
225
Live webinar: Intravascular Lithotripsy (IVL) in PAD—clinical benefits and the real-world economic considerations that drive adoption.
March 25, 2026 • 7:00 PM ET • 60 minutes
CME/CE credit types available (CME, CNE, AANP, AAPA, CCI)
Save your seat: hubs.ly/Q044Kc5j0
229
Heart failure care is shifting from reactive to proactive.
Matthew H. Gonzalez, MD explains how pulmonary artery pressure monitoring w/ the #CardioMEMS HF System supports earlier intervention and coordinated HF care.
Watch:
hubs.ly/Q043FWQr0
#CardioTwitter #HeartFailure
1
209
Heart failure care is shifting from reactive to proactive.
Matthew H. Gonzalez, MD explains how pulmonary artery pressure monitoring w/ the #CardioMEMS HF System supports earlier intervention and coordinated HF care.
Watch:
hubs.ly/Q043nRct0
#CardioTwitter #HeartFailure
185
